Status:
RECRUITING
Multifrequency MRE in Evaluation of Chronic Kidney Diseases
Lead Sponsor:
Shengjing Hospital
Conditions:
Chronic Kidney Disease (CKD)
Eligibility:
All Genders
18-65 years
Brief Summary
Chronic Kidney Disease (CKD) is a major public health issue, leading to high mortality and the necessity for renal replacement therapy. Kidney fibrosis, resulting from chronic damage to kidney tissue,...
Detailed Description
Chronic Kidney Disease (CKD) is a significant public health concern, impacting approximately 10% of the global population. Annually, millions face mortality or require renal replacement therapy due to...
Eligibility Criteria
Inclusion
- CKD patients at stages 1-5 .
- Ages 18-65, all sexes and genders.
- Subjects who have undergone renal MRI.
- Hospitalized for renal biopsy with histopathological examination; MRE sequence scanning completed within 3 days prior to renal biopsy.
Exclusion
- Patients with a cardiac pacemaker or other implanted electronic devices that are not MRI compatible
- Patients who are pregnant or suspected to be pregnant
- Patients with severe claustrophobia or anxiety
- Patients who can not tolerate MRE
- Patients who do not sign informed consent
- Patients with acute exacerbation of chronic kidney disease, with creatinine levels rising more than 20% within one month or diagnosed with acute kidney injury (AKI).
Key Trial Info
Start Date :
April 28 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 8 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06202235
Start Date
April 28 2023
End Date
December 8 2026
Last Update
February 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shengjing Hospital of China Medical University
Shenyang, Liaoning, China, 110004